Tech Company Financing Transactions
Adamas Pharmaceuticals Funding Round
Adamas Pharmaceuticals closed a $40 million Series D funding round on 8/19/2009. Backers included Aeris Capital AG, DAG Ventures and Mohr Davidow Ventures.
Transaction Overview
Company Name
Announced On
8/19/2009
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors
Aeris Capital AG (Lead Investor) (George Rehm)
Mohr Davidow Ventures (William Ericson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1900 Powell St. 750
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Went
Chief Financial Officer
Alfred Merriweather
Chief Financial Officer
Christopher Prentiss
Chief Medical Officer
Rajiv Patni
VP - Bus. Development
Sarah Mathieson
VP - Bus. Development
Vijay Shreedhar
VP - General Counsel
Jennifer Rhodes
Browse more venture capital transactions:
Prev: 8/19/2009: Wanova venture capital transaction
Next: 8/19/2009: 3VR Video Intelligence Platform venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs